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Abstract
Mycobacteriaceae comprises pathogenic species such as Mycobacterium tuberculosis,
M. leprae and M. abscessus, as well as non-pathogenic species, for example, M. smegmatis
and M. thermoresistibile. Genome comparison and annotation studies provide insights into
genome evolutionary relatedness, identify unique and pathogenicity-related genes in each
species, and explore new targets that could be used for developing new diagnostics and
therapeutics. Here, we present a comparative analysis of ten-mycobacterial genomes with
the objective of identifying similarities and differences between pathogenic and non-patho-
genic species. We identified 1080 core orthologous clusters that were enriched in proteins
involved in amino acid and purine/pyrimidine biosynthetic pathways, DNA-related processes
(replication, transcription, recombination and repair), RNA-methylation and modification,
and cell-wall polysaccharide biosynthetic pathways. For their pathogenicity and survival in
the host cell, pathogenic species have gained specific sets of genes involved in repair and
protection of their genomic DNA. M. leprae is of special interest owing to its smallest
genome (1600 genes and ~1300 psuedogenes), yet poor genome annotation. More than
75% of the pseudogenes were found to have a functional ortholog in the other mycobacterial
genomes and belong to protein families such as transferases, oxidoreductases and
hydrolases.
Author summary
Members of the Mycobacteriaceae family, which are known to adapt to different environ-
mental niches, comprise bacterial species with varied genome sizes. They are unique in
their cell-wall composition, which is remarkably thick and lipid-rich as compared to other
bacteria. We performed a comparative analysis at the proteome level for ten mycobacterial
species that differ in their pathogenicity, genome size and environmental niches. A total
of 1080 orthologous clusters with representation from all ten species were obtained, and
these were further examined for their domain annotations, domain architecture similari-
ties and enriched GO terms. These core orthologous clusters are enriched in various bio-
synthetic pathways. The proteins that are specific to each of the ten species were also
investigated for their GO functions. The M. leprae genome has a large number of pseudo-
genes and we searched for their functional orthologs in other mycobacterial species in
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order to understand the functions that are lost from the M. leprae genome. The proteins
present exclusively in M. leprae genome were studied in more detail, in order to predict
putative drug targets and diagnostic markers. These findings, which have implications in
understanding evolution of mycobacterial genomes, identify species-specific proteins that
have potential for use in developing new diagnostic tools and therapeutics.
Introduction
Mycobacteriacea are known etiological agents for a variety of human infections and are broadly
classified as Mycobacterium tuberculosis (M. tuberculosis) complex (MTBC) and Non-Tubercu-
lous Mycobacteria (NTM). The MTBC includes several pathogenic species including M. tuber-
culosis that causes tuberculosis (TB) in ~10.4 million people across the globe each year. In the
year 2015, ~1.4 million deaths were reported due to TB and additionally, 0.4 million deaths
occurred as a result of TB infection in HIV patients [1]. Other obligate intracellular pathogenic
species include M. leprae that causes leprosy in ~200,000 people annually and is mainly con-
fined to endemic countries in the tropical zones [2]. NTMs on the other hand cause opportu-
nistic infections and are a growing concern for a plethora of varied atypical systemic infections
[3]. Currently there are more than 140 species of NTMs, some of which lead to pulmonary dis-
eases, otitis media, osteomyelitis, lymphadenitis and skin and soft tissue infections (SSTIs) in
humans [4]. One of the NTM that deserves a specific mention is a free-living rapidly growing
species, M. abscessus, which is regarded as a new antibiotic nightmare that causes opportunistic
infections in patients with cystic fibrosis or chronic pulmonary disease, and/or skin and soft-
tissue infection [5].
The availability of the genome sequence data for several mycobacterial species, together
with a variety of bioinformatics software and methods for genome analysis, makes it feasible
for researchers to annotate genomes and collate information related to evolutionary traits,
sequence homology, conserved regions, domain architecture, structural properties of gene
products and gene ontology (GO) content. Comparative functional annotation of proteins
from the genome sequencing data for pathogenic and non-pathogenic mycobacterial species
can provide information related to phylogeny, frequency & distribution of orthologous protein
clusters (clusters of gene families obtained from sequence comparisons of multiple species that
usually reflect common functions), overlap between functional networks and species specific
unique gene products [6]. This information is vital for identifying potential drug targets and
unique regions/gene products that provide opportunities for developing effective diagnostic
tools with considerable sensitivity and specificity.
The resulting mycobacterial genome annotations also provide an extremely useful resource
for understanding strain variation and pathogenicity. The emergence of multidrug resistant
and extremely drug-resistant strains underlines the need to understand orthologous genes and
to identify potentially druggable targets. Earlier attempts to compare mycobacterial genomes
provided information about pairwise whole-genome similarities and their predicted prote-
omes [7]. Since the determination of the complete genome sequence of M. tuberculosis, there
have been efforts to develop inventories that record information on open reading frames
(ORFs) annotations and gene expression [8–11], drug resistance mutations and drug targets
[12–15], phylogenetic relationships [16,17], pathogenomics, and structure and function anno-
tation of the mycobacterial genome [18,19].
In the current study, we have chosen ten different species—M. tuberculosis, M. abscessus,
M. leprae, M. marinum, M. avium, M. kansasii, M. thermoresistible, M. smegmatis, M. ulcerans
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and M. vanbaalenii—for comparative analysis of genomes and protein functions. The set
being investigated encompasses pathogens, opportunist pathogens and non-pathogenic spe-
cies. Here we describe the mapping of orthologous clusters across the species in terms of
their gene products to identify conserved regions and species-specific unique proteins from
the predicted proteomes. Further, phylogenetic linkages are defined and GO annotations
assessed to identify functional similarities and differences between protein targets from vari-
ous species.
Of these mycobacterial species, M. leprae is under-represented in most of the known myco-
bacterial databases and comparative genome studies. It has the smallest genome (due to reduc-
tive evolution) among known mycobacterial genomes and a limited set of predicted proteins
while half of its genome is occupied by pseudogenes [20]. Here we describe the search for func-
tional orthologs of the pseudogenes in other mycobacterial species, to gain insight into the set
of functions lost from the M. leprae genome. M. leprae has a genome size of 3,268,210 bp with
only ~1600 genes, of which 22% are hypothetical proteins with unknown functions [20]. This
poor annotation is also reflected by just a handful of solved protein structures (13 structures as
of 23rd April 2017) in the Protein DataBank (PDB). Further, it poses clinical challenges as it
has a very long generation time of 14 days, is an unculturable pathogen that lacks reliable and
specific molecular markers for diagnosis of the disease. Here we report a study of the unique
proteins present in the genome of M. leprae for their GO functions, subcellular and transmem-
brane localization, gene expression profiles from a GEO dataset, essentiality, virulence and the
presence of human orthologs.
Methods
Mycobacterial genomes
The ten mycobacterial genomes (Table 1) investigated in the present study were downloaded
from UniProt [21]. These mycobacterial species cover different genome sizes and environmen-
tal niches. In the pathogenic group, we included the most virulent mycobacteria [22]: M. tuber-
culosis,M. leprae, M. marinum (infects broader variety of hosts and causes lesions characterized
by granulomas) and M. ulcerans (causes third-most common mycobacterial disease after tuber-
culosis and leprosy). The opportunist pathogenic group includes NTMs that cause pulmonary
and other peripheral infections in immunocompromised individuals. These definitions are
adapted from an earlier comparative study of metabolic pathways of the mycobacterial species
[22].
Table 1. Mycobacterium species used in the study and properties of their genomes.
Mycobacterium sp Strain used Uniprot Accession Genome Size (bp) No of proteins (chromosomal) Nature of species/virulence
M. tuberculosis h37rv UP000001584 4,411,532 3993 Pathogen
M. leprae TN UP000000806 3,268,203 1603 Pathogen
M. ulcerans agy9 UP000000765 5,631,606 4131 Pathogen
M. marinum M UP000001190 6,636,827 5389 Pathogen
M. smegmatis mc2155 UP000000757 6,988,209 6601 Non-pathogenic
M. vanbaalenii pyr1 UP000009159 6,491,865 5902 Non-pathogenic
M. thermoresistibile ATCC19527 UP000004915 unassembled WGS 4612 Non-pathogenic
M. avium 104 UP000001574 5,475,491 5040 Opportunistic pathogen
M. abscessus ATCC19977 UP000007137 5,067,172 4918 Opportunistic pathogen
M. kansasii ATCC12478 UP000017786 6,432,277 5689 Opportunistic pathogen
https://doi.org/10.1371/journal.pntd.0005883.t001
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Identification of orthologs
Orthologs were identified in the ten species using ProteinOrthov5 [23]. Sets of orthologs that
are shared across all species and between a given pair of species were identified. The remaining
sets of proteins from each species that failed to identify an ortholog in any other nine species
were marked as species-specific proteins. The clusters of orthologs that have representation
from all the ten species are called core orthologs (gene families present in all ten species).
Domain composition and architecture similarity in orthologs
For all the orthologous clusters identified, irrespective of the number of genes and species, we
looked at the domain composition and architectural similarities in order to identify the func-
tional similarities at the genome level.
For calculating the similarity in domain composition, for a given cluster, all pairwise ortho-
logs were considered and were assigned Pfam domains using hmmscan from the HMMER3
package [24] and Pfam v30 database [25] at an E-value threshold of 10−3. For each of these
pairs having representation in two species, we then calculated the fraction of shared domains,
known as the domain composition similarity score (DCS, Eq 1), which can range from 0 to 1,
where 1 indicates that the given pair of orthologs has exactly the same domain composition
and a score close to zero reflects poor similarity in domain composition. If there are in-para-
logs in the orthologous cluster, then the presence of a Pfam domain in at least one of these is
sufficient to be included in the count as a shared domain.
DCS¼ sd12=N ð1Þ
where sd12 is the number of shared domains between protein p1 and p2 and N is the total
number of non-redundant domains in p1 and p2.
The second level of similarity is more stringent as it considers both the order and the con-
tent of domains and is called the domain architecture similarity score (DAS, Eq 2). DAS,
adapted from Forslund et al. [26], is calculated for each pair in the orthologous cluster and
considers the number of identical aligned Pfam domains compared to the total number of
domains in the pair.
DAS ¼ al12=N ð2Þ
where al12 is the number of domains that are aligned with an identical domain in two given
proteins p1 and p2 and N is the total number of domains in the two given proteins.
Gene ontology (GO) term enrichment analysis
We mapped both core orthologs and species-specific sets of proteins to GO terms in all the
three domains (biological process, molecular function and cellular component) by considering
the following evidence codes as reliable: IMP: Inferred by Mutant Phenotype, IGI: Inferred by
Genetic Interaction, IPI: Inferred by Physical Interaction, IDA: Inferred by Direct Assay, IEP:
Inferred by Expression Pattern, ISS: Inferred by Structure/Sequence Similarity, TAS: Traceable
Author Statement and IC: Inferred by Curation.
In order to reduce the number of GO terms and map them to broader categories, we used
GOSlimViewer from AgBase [27] to map the set of proteins to GO Slim terms (broader ver-
sions of the GO ontologies that provide a summary of results of GO annotation).
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To identify the GO terms enriched in a specific subset of interest, hypergeometric probabil-







where M is the total number of GO terms in the subset, N is total number of GO terms full set,
n and x is the occurrence of a GO term of interest in the full set and the subset respectively. To
identify significantly enriched GO terms in the core orthologous set, p-values were calculated
using hypergeometric distribution. The GO terms were considered enriched if the p-values
were less than 0.05.
Pseudogenes in Mycobacterium leprae
We used the nucleotide sequence of 1320 pseudogenes present in M. leprae and performed
BLASTX against the remaining nine-mycobacterial proteomes to determine whether there is a
functional ortholog present. To gain insights into the functions of these lost genes, we mapped
the functional orthologs of pseudogenes identified in the M. tuberculosis genome to the protein
families
Species specific proteins
The species-specific proteins were further mapped to their GO functions to identify the
enriched GO functions for all ten species using Eq 3. The M. leprae species-specific proteins
were studied in detail in order to explore their potential to be used either as diagnostic markers
or new drug targets. The linear B-cell epitopes for these specific proteins using BepiPred (at a
threshold of 0.35) and selected the ones that are between 10–30 amino acids in length.
Results and discussion
Mycobacterial genomes
The genome sizes of the two obligate pathogenic species, M. tuberculosis and M. leprae, are
smaller than those of the free living non-pathogenic and opportunist pathogenic genomes (Fig
1). This is in agreement with previous observations of genome reduction and loss of genes
when free-living bacteria adapt to an obligate pathogenic lifestyle [28]. However, M. marinum,
a pathogen that can cause tuberculosis-like infections in aquatic organisms (fishes and
amphibians) and can also cause peripheral disease characterized by granulomas in humans,
has retained a higher genome size and a larger number of genes. This can be explained by its
ability to infect broader range of hosts and its capacity to survive outside the host. Also, its
genome is reported to have large number of polyketide synthases and non-ribosomal peptide
synthases, PE and PPE proteins, secretion system proteins [29].
Orthologous clusters
We identified 6983 orthologous clusters that have representation from at least two of the ten
species. Of these 6013 were single gene clusters (one-to-one orthologs), whereas remaining
970 clusters had in-paralogs. There were 1080 clusters that have representation of all the spe-
cies and the proteins forming these clusters are labeled as core orthologs (Fig 2).
The orthologous clusters shared between any two-mycobacterial genomes were also
recorded in order to identify closely related mycobacterial genomes (S1 Table). Among the
pathogenic species, M. tuberculosis, M. leprae and M. ulcerans share the maximum number of
orthologous pairs with another pathogenic species M. marinum, which has a remarkably larger
Similarities and differences in mycobacterial genomes
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genome (as discussed above). Consistent with its ability to live without the host, M. marinum
shares maximum similarity with an opportunist pathogenic species M. kansasii. For the non-
pathogenic species, the maximum similarity was shared within the other non-pathogenic spe-
cies. The opportunist pathogenic species M. abscessus is observed to share maximum similarity
with a free-living non-pathogenic species M. smegmatis. These observations correlate with the
environmental niches of these species and that they have preserved the higher number of
genes and have also acquired genes through horizontal gene transfer unlike pathogenic species,
which have adopted an evolutionary route to minimalism (and genome reduction) to maintain
their growth efficiency and competitiveness inside the host.
As M. leprae has the smallest genome with only 1600 protein coding genes, we excluded the
genome of M. leprae and then repeated the ortholog identification step for the remaining nine
species (S1 Fig). Although this was not observed to increase the number of orthologous clus-
ters, the number of core orthologs (gene families present in nine mycobacterial species)
increased by 40% (10,910 proteins from all ten species vs. 15,043 proteins from all nine species-
excluding M. leprae).
Domain composition and architecture. Upon identifying orthologous clusters, we
assessed the functional similarities within these clusters by investigating Pfam domain compo-
sitions for pairwise alignments (S2 Fig and Fig 3). To address the differences in the numbers of
orthologous clusters, we calculated the average of the domain composition scores for each pair
of species. As expected, pathogenic species have retained maximum functional similarities
among themselves as they have adapted themselves to a host-dependent lifestyle. Conversely,
opportunists and non-pathogenic species were less similar in terms of domain composition of
orthologs reflecting less evolutionary selection of common domains and genes. The orthologs
of M. marinum and M. ulcerans were more closely related with a maximum domain composi-
tion overlap (fraction of shared domains) of 0.98, which supports their evolution from a recent
common ancestor [30].
Fig 1. The sizes of mycobacterial genomes in relation to the number of genes. The pathogenic mycobacterial species are
shown in red, in black are the species that cause opportunistic infections and non-pathogenic species are shown in green.
Mycobacterium leprae’s genome has undergone reductive evolution and has the smallest genome, whereas the free-living
Mycobacterium smegmatis has the largest genome.
https://doi.org/10.1371/journal.pntd.0005883.g001
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We also looked at the conservation of domain order in orthologous pairs. Fig 3 highlights
this for M. tuberculosis, where the average domain-architecture similarity scores are plotted for
comparison with nine other species. We calculated DAS for all orthologous clusters, one-to-
one clusters (no in-paralogs (duplicated in the same genome)) and duplicated clusters (in-
paralogs present). The one-to-one clusters (orthologs) retain more conserved domain architec-
ture as compared to the in-paralogs as seen in Fig 4, which reflects that orthologs are under
stronger evolutionary selection pressure than the paralogs to retain the same functions [26].
The orthologs from two pathogenic species M. leprae and M. tuberculosis were observed to
have the highest domain architecture similarity indicating the functional similarities, as
described later.
Functional annotation of core orthologs and species-specific proteins. We selected the
proteins from ten species that form the 1080 orthologous clusters (10,980 proteins) and stud-
ied these for the presence of enriched GO terms using the total number of proteins in all ten
species as a background. Table 2 lists the GO Slim terms. Full lists of GO functions, which are
clubbed into these broader GO Slim terms, are provided as S2 Table.
Fig 2. Orthologous clusters in ten species. A. The number of orthologous clusters having representation from different mycobacterial species. The
core orthologs with representation from all ten species form 1080 clusters, while there are 7892 proteins from all ten species which are species-specific
and do not find orthologs in any other species. B. Species-wise representation of orthologous clusters. The bar proximal to the y-axis corresponds to the
number of species-specific proteins, whereas the most distal bar represents the number of proteins shared across all species.
https://doi.org/10.1371/journal.pntd.0005883.g002
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The core orthologs are enriched in functions involved in processes that are essential for the
organism to grow and survive such as amino acid and purine/pyrimidine biosynthetic path-
ways, DNA related processes (replication, transcription, recombination and repair), RNA-
methylation and modification and cell wall polysaccharide biosynthetic pathways. Many of
these biosynthetic pathways such as the chorismate pathway, which is involved in biosynthesis
of aromatic amino acids, are essential in mycobacterial species [31,32], which explains their
enrichment in the core orthologous sets.
Apart from essentiality, another interesting observation is the existence of persistors in
mycobacterial infections, as in other bacterial infections [33]. Persistors give rise to drug treat-
ment failure and relapse of the disease apart from the growing concern of antibiotic resistant
bacterial strains. The persistors are genetically similar to the drug-sensitive population but
they enter the slow-growing or dormant state to evade the effects of bactericides. Recently, it
has been shown that M. tuberculosis high-persistor mutants have altered biochemical pathways
of amino acid and lipid biosynthesis [33–35]. This supports our observation that the proteins
involved in carbon metabolism pathways are conserved across mycobacterial species and that
the genes involved in biosynthetic pathways are enriched in the core orthologs. Apart from the
fact that they are required for growth and survival, these genes are associated with virulence
and drug evasion and hence in providing better adaptability to their respective environmental
niches.
We further examined the overlap between the known and proposed drug targets for M.
tuberculosis in the set of core orthologs to note the representation of these drug targets in
other mycobacterial genomes. We collated the list of known potential drug targets for M.
tuberculosis from several studies [36–42] including the predicted targets from the Tropical
Fig 3. Sharing of domains between orthologs. For all the pairwise species, the average domain composition score is plotted. MYCTU: M.
tuberculosis, MYCS2: M. smegmatis, MYCUA: M. ulcerans, MYCA9: M. abscessus, MYCTH: M. thermoresistible, MYCA1: M. avium,
MYCLE: M.leprae, MYCKA: M. kansasii, MYCVP: M. vanbaalenii, MTCMM: M. marinum. In asterisk are the species that belong to same
class namely: pathogenic and pathogenic, opportunists and opportunists, non-pathogenic and non-pathogenic.
https://doi.org/10.1371/journal.pntd.0005883.g003
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Disease Research (TDR) Targets Database [37]. ~60% of the non-redundant drug targets fall
into the set of core orthologs (S3 Fig) and ~95% are present in at least one other mycobacterial
genome. This set will serve as a useful and potential starting point to explore new drug targets
for treating other mycobacterial infections based on their essentiality and degree of conserva-
tion in the different pathogenic mycobacterial species.
Pathogenic vs. non-pathogenic genomes
In order to understand and explore the molecular and structural biology of the drug targets for
pathogenic mycobacterial species such as M. tuberculosis and M. abscessus, non-pathogenic
species (M. smegmatis and M.thermoresistibile) are usually used as surrogate systems and mod-
els in the lab [43,44]. This enables researchers to work with non-infectious strains on the
bench and also M. thermoresistibile proteins can tolerate higher temperatures than the M.
tuberculosis proteins and on average are more soluble [44].
To investigate the suitability of using non-pathogenic species as surrogate systems for path-
ogenic species, we checked the similarity of the orthologous pairs between non-pathogenic
and pathogenic species (S4 Fig). The orthologs of pathogenic species (M. ulcerans, M. tubercu-
losis, M. leprae and M. marinum, S4A and S4B Fig in red) present in M. smegmatis and M. ther-
moresistibile genomes were observed to share more than 70% average percent identity. But for
the opportunist pathogens (M. abscessus, M. avium and M. kansasii, S4A and S4B Fig in black),
the distribution of percent identity is much wider and median is below 70% indicating that
non-pathogenic species M. smegmatis and M. thermoresistibile are more suitable surrogate
models for studying the proteins of pathogenic species such as M. tuberculosis.
Fig 4. Conserved domain order in orthologs. The average domain architecture similarity score for M. tuberculosis with all other nine
species. The score is higher where there is no gene duplication as compared to when in-paralogs are present. MYCTU: M.tuberculosis,
MYCS2: M. smegmatis, MYCUA: M. ulcerans, MYCA9: M. abscessus, MYCTH: M. thermoresistible, MYCA1: M. avium, MYCLE: M.
leprae, MYCKA: M. kansasii, MYCVP: M. vanbaalenii, MTCMM: M. marinum.
https://doi.org/10.1371/journal.pntd.0005883.g004
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Pseudogenes in M. leprae
M. leprae has adapted to become an obligate pathogen and its genome has undergone a huge
reduction to only 1600 protein-coding genes and large number of pseudogenes (1320) [20,45].
We inspected the other nine-mycobacterial genomes for the presence of functional orthologs
of these pseudogenes in order to gain insight into what functions have been lost from the
M. leprae genome during the process of genome reduction.
More than 75% of the pseudogenes were found to have a functional ortholog in the
genomes of pathogenic and opportunist pathogenic species (except for M. abscessus, which
had an ortholog for 61% of the pseudogenes, Fig 5A). However, the fraction of pseudogenes
having a functional ortholog in non-pathogenic species was around 70% (M. smegmatis- 70%,
M. thermoresistible- 64% and M. vanbaalenii- 71%).
Upon mapping the functional orthologs of pseudogenes identified in the M. tuberculosis
genome to the protein families (Fig 5B), we noted that these were mainly associated with the
catabolic functions such as transferases (including acetyltransferase, acyltransferase, methy-
transferase, transaldolase, transketolase, transaminase), oxidoreductases (including dehydro-
genase and peroxidase) and hydrolases (including lipase, amylase, protease, phosphatase)
thereby limiting the availability of usable energy source for M. leprae to grow. This is consistent
with other studies, where they have analyzed the genome reduction and loss of functions in
M. leprae genome [20,46,47]. As mentioned earlier, the proteins for all major biosynthetic
pathways are fairly conserved between all mycobacterial species (as they are found in core
orthologous clusters) but the energy metabolism genes appear to be more tuned to different
species needs as they have evolved to survive in specific environmental niches with different
growth rates.
Table 2. Function annotation of orthologs common to all species. The core orthologs from all ten myco-
bacterial species were examined to identify the enriched GO terms.
GO Slim ID GO Slim Term pvalue
Biological process
GO:0006520 cellular amino acid metabolic process 2.31E-125
GO:0009058 biosynthetic process 1.25E-100






GO:0005198 structural molecule activity 1.72E-197
GO:0005488 binding 2.01E-26
GO:0005515 protein binding 7.81E-14
GO:0008565 protein transporter activity 8.24E-32
GO:0008907 integrase activity 3.19E-07
GO:0016301 kinase activity 9.71E-09
GO:0016740 transferase activity 8.25E-33
GO:0016787 hydrolase activity 6.54E-05
GO:0016829 lyase activity 1.36E-13
GO:0016853 isomerase activity 8.74E-25
GO:0016874 ligase activity 2.02E-45
GO:0030234 enzyme regulator activity 0.03
https://doi.org/10.1371/journal.pntd.0005883.t002
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Species-specific proteins
We also looked at the enriched GO functions in species-specific proteins for all ten species
(S3–S5 Tables). In the pathogenic species, we noticed that the genomes of M. tuberculosis and
M. marinum were enriched in functions that are involved in DNA metabolism such as DNA
recombination, DNA repair, DNA integration and protection (S3 Table). This supports the
observation that DNA repair mechanisms are active throughout the course of tuberculosis
infection as observed in infection models and clinical samples [48]. Once these pathogens
infect the host, they need to survive the hostile environments inside the host cells and hence
DNA repair and recombination are required to preserve the integrity of their genomes. Apart
from surviving in the host-cell environment during the various stages of the infection cycle,
there is a need for DNA repair and recombination mechanisms to preserve the genome during
dormant phases of infection [49,50].
In the set of opportunistic pathogens (M. abscessus, M. avium and M. kansasii) specific
genes, functions and processes associated with membrane transport such as the ATP-binding
cassette transporter complex, high-affinity iron permease complex and oxidoreductase activity
are enriched (S4 Table). The fact that the genome of M abscessus is known to code for many
drug-efflux proteins such as ATP-binding cassette transporters and MmPL proteins [51,52] is
consistent with its observed multidrug resistance. Furthermore, as these are free-living bacte-
ria, the presence of enriched and active transport systems helps their survival through uptake
of nutrients and acquisition of genes via horizontal gene transfer.
Fig 5. Pseudogenes in Mycobacterium leprae genome and their functional ortholog in other mycobacteria. A. The number of pseudogenes with
a functional ortholog in other mycobacterial species. MYCTU: M. tuberculosis, MYCS2: M. smegmatis, MYCUA: M. ulcerans, MYCA9: M. abscessus,
MYCTH: M. thermoresistible, MYCA1: M. avium, MYCKA: M. kansasii, MYCVP: M. vanbaalenii, MYCMM: M. marinum. B. The functional orthologs of
the pseudogenes present in M. tuberculosis, mapped to the protein families to reflect their possible functions.
https://doi.org/10.1371/journal.pntd.0005883.g005
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Diagnosing and treating M. leprae infections remain huge challenges due to its slow growth
rate, lack of specific and reliable clinical markers and emerging drug resistance. We have there-
fore studied this genome in detail to identify the gene(s) that are specific to its genome, in
order to identify and propose genes that can be further tested and validated for use as diagnos-
tic markers and/or drug targets [53].
While comparing the genes of the ten-mycobacterial species, 141 M. leprae proteins were
identified that lack a homolog in any of the other nine species. We further screened these 141
proteins for homologs against other mycobacterial genomes (from NCBI), and identified
86 M. leprae proteins that lack an ortholog in any other mycobacterial genomes (S5 Fig).
Firstly, we scanned these 86 M. leprae specific proteins for their GO functions, transmembrane
regions, presence of a human ortholog, and for their predicted essentiality, using Flux-balance
analysis, from PATRIC database [10,11]) and virulence (S6 Table). Interestingly, none of the
86 had a human ortholog nor was predicted to be essential or involved in virulence. As these
essentiality predictions are based on only flux-balance analysis, it would be interesting to
design experiments for testing their essentiality for M. leprae.
We studied these M. leprae-specific proteins for their potential to be used either as diagnos-
tic markers or new drug targets. Therefore, synthetic peptides presenting these epitopes could
be used to raise antibodies, which can be used to detect the specific protein in a diagnostic test.
Predicting the linear antigenic determinants is usually an initial step to determine antigenicity
followed by prediction of non-continuous or conformational epitopes that are generally linear
epitopes that are in close structural proximity upon folding. We mapped the linear B-cell epi-
topes for these specific proteins using BepiPred [54] (S7 Table). This is an initial step towards a
search for B-cell antigens in the genome of M. leprae, which would aid to identify the antigenic
determinants in this pathogenic mycobacterial species. The linear B-cell epitopes are predicted
using the sequence information only; hence these provide a feasible way to run predictions at
the genome-wide level, however, their accuracy rates are only about ~60–70% and more exper-
imental validations are required to test these predictions. We could find 127 antigenic determi-
nants in 69 of these specific proteins, which might serve as a good starting point for further
experimental validations and developing diagnosis tools for leprosy (S7 Table).
In the species-specific M. leprae proteins, we investigated in detail ML2177c, which encodes
for a probable uridine nucleoside phosphorylase (an important enzyme in the salvage pathway
for nucleotide synthesis). This enzyme is of interest due to the following observations: a. avail-
ability of a suitable structural homolog to model the structure; b. lack of a uridine phosphory-
lase in M. tuberculosis genome [55–57], hence it can be specific for leprosy infection; c. known
immunogenicity in both animal models and infected humans [58], which might aid in diagno-
sis of leprosy infection; and d. it is already being explored as a drug target for other bacterial
infections such as Salmonella typhimurium [59]. We have also performed a transcriptomics
analysis, to check the expression levels of ML2177c in patients (n = 3) with M. leprae infection
from endemic regions. We measured the fold change in the expression levels of ML2177c as
compared to the basal level of expression (16S rRNA). For two of the samples, the change of
expression was two-fold and for one of the samples four-fold, indicating ML2177c is signifi-
cantly expressed during leprosy infection. We also observed that ML2177c is conserved in
strains of M. leprae other than TN (namely Br4923, NHDP63 and Thai).
We inspected ML2177c for its druggability by predicting the hotspots in the protein struc-
ture model. We first modeled the protein structures using our in-house automated modeling
pipeline (Vivace) [18], followed by prediction of the druggable sites using our software for frag-
ment hotspot mapping (Fig 6A) [60], which provides insights into the ligand binding site for
the target. Using the known oligomeric structure for uridine phosphorylase for Shewanella
oneidensis (PDB ID: 4R2X, 30% identity with ML2177c) as a template, we modeled the
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hexameric complex for ML2177c. The inhibitor 2,2’-anhydrouridine was modeled into the
hexameric structure using the S. typhimurium structure (PDBID: 3FWP). The fragment hot-
spot maps to the dimeric interface of the modeled structure and superposes with the inhibitor-
binding site, hence suggesting the druggability of ML2177c (Fig 6B).
Conclusions
We believe that the comparative genomic studies provide insights into understanding the
common mechanisms of mycobacterial pathogenesis, including pathways and functions con-
served across different species. Also examining these different mycobacterial genomes for spe-
cific proteins should help distinguish the mycobacterial infection, as well as aid in designing
new therapeutics and in testing some for their use in developing diagnostic kits for specific
mycobacterial infections.
Here, we have highlighted functions both common and specific to different mycobacterial
species. Interestingly, the drug targets predicted for M. tuberculosis were found to have ortho-
logs in other mycobacterial genomes, suggesting their suitability as a drug target for treating
other mycobacterial infections.
In our opinion, it is of value to explore the large number of pseudogenes that are retained
in the M. leprae genome in more detail. Their orthologs in M. tuberculosis are reported to be
non-essential but a significant proportion of these, ~43%, are observed to be expressed at dif-
ferent levels during different stages of disease progression [61,62]. However, the expressed
pseudogenes are observed to have altered ORFs because of the large number of stop codons,
the lack of start codons and their presence usually towards the end of the 3’ end of the operon.
As essential and functional genes tend to be present towards the 5’ end, this appears to be an
example of position-dependence of functionally significant genes [63]. The sequence compari-
sons of these pseudogenes in different strains of M. leprae reveal that some of these pseudo-
genes are strain specific, possibly implicating their role in generating genetic diversity, but
more likely a reflection of selectively neutral evolution. Regarding their functions, it is pro-
posed that they play important roles in regulation of gene expression at both transcriptional
and post-transcriptional level, serve back-up functions and can be activated by phenomena
Fig 6. Structure modeling of Mycobacterium leprae specific protein (ML2177c) and predicting the druggable sites. A. Protomer from the
hexameric structural model of ML2177c, with the predicted hotspots shown on the surface, in yellow where the hydrophobic fragments map, blue for
hydrogen-bond donors, and red for hydrogen-bond acceptor. B. The dimer of the template (PDBID: 4R2X) is shown in cyan and magenta, and the
homology model of ML2177c is in green. The inhibitor (2,2’-anhydrouridine), modeled into the dimer using the inhibitor-bound structure of uridine
phosphorylase (PDBID: 3FWP), is shown in gray spheres and the phosphate is shown in red spheres.
https://doi.org/10.1371/journal.pntd.0005883.g006
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such as gene conversion, regulate replication rates and rate of infection [20]. More detailed
analysis on the pseudogenes in mycobacterial genomes will shed light into evolution and
understanding their role during stages of infection.
Supporting information
S1 Table. Pairwise similarities between mycobacterial genomes. The matrix reflects the
number of orthologous clusters having representation from any two given mycobacterial spe-
cies. The maximum similarity in terms of having the maximum number of orthologous pairs
between two genomes is marked in bold red and is represented row-wise.
(PDF)
S2 Table. GO terms included in the GO Slim terms. For the core orthologs, we calculated the
pvalues using hypergeometric distribution to find the enriched GO Slim terms. This table lists
all the GO terms that are classified under the respective GO Slim terms to give a more detailed
name of the GO process and function.
(XLSX)
S3 Table. GO enriched terms in species-specific set of pathogenic species (M. tuberculosis,
M. ulcerans, M. leprae and M. marinum).
(PDF)
S4 Table. GO enriched terms in species-specific set of opportunistic species (M. abscessus,
M. avium and M. kansasii).
(PDF)
S5 Table. Go enriched terms in species-specific set of non-pathogenic species (M. smegma-
tis, M. thermoresistible and M. vanbaalenii).
(PDF)
S6 Table. Mycobacterium leprae specific proteins. The unique proteins present in the
genome of M. leprae mapped for their GO functions, subcellular and transmembrane localiza-
tion, gene expression profiles from a GEO dataset (under-expressed in green, over-expressed
in red), essentiality (flux balance based predictions), virulence and presence of human ortho-
logs.
(PDF)
S7 Table. Predicted linear B-cell epitopes in Mycobacterium leprae specific proteins.
(PDF)
S1 Fig. Orthologous clusters upon removal of Mycobacterium leprae. A. Species-wise repre-
sentation of ortholog clusters. The bar proximal to the y-axis represents the proteins shared
across all species, whereas the most distal bar represents the species-specific proteins. B. The
number of genes present in the cluster that share a given number of species including and
excluding M. leprae.
(TIF)
S2 Fig. Domain sharing in orthologs. Domain composition scores for: A. Pathogenic vs.
pathogenic species, all the scores mostly lie between 0.7–1.0, B. Opportunists vs. opportunists,
C. Non-pathogenic vs. non-pathogenic. For B and C score below 0.5 are also seen. D. Patho-
genic and opportunists- share high functional similarities, E. Pathogenic and non-pathogenic
and F. Opportunists and non-pathogenic. MYCTU: M. tuberculosis, MYCS2: M. smegmatis,
MYCUA: M. ulcerans, MYCA9: M. abscessus, MYCTH: M. thermoresistible, MYCA1:
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M. avium, MYCLE: M.leprae, MYCKA: M. kansasii, MYCVP: M. vanbaalenii, MTCMM:
M. marinum.
(TIF)
S3 Fig. Drug targets in Mycobacterium tuberculosis and their representation in other myco-
bacterial species. The representation of predicted targets for M. tuberculosis in other mycobac-
terial genomes.
(TIF)
S4 Fig. Distribution of percent identities of orthologs of M. smegmatis and M. thermoresis-
tibile with other pathogenic mycobacterial species. A. Box-plot showing the distribution of
percent identities between the orthologs of pathogenic species (shown as red boxes) and
orthologs of opportunist pathogenic species (shown as black boxes) with their orthologs in
M. smegmatis genome. B. Box-plot showing the distribution of percent identities between the
orthologs of pathogenic species (shown as red boxes) and orthologs of opportunist pathogenic
species (shown as black boxes) with their orthologs in M. thermoresistibile genome. The
abbreviations in the figure used are as follows: ulcerans_smeg: M. ulcerans vs.M. smegmatis,
tb_smeg: M. tuberculosis vs.M. smegmatis, lep_smeg: M. leprae vs.M. smegmatis, mar_smeg:
M. marinum vs.M. smegmatis, ab_smeg: M. abscessus vs.M. smegmatis, avium_smeg: M.
avium vs. M. smegmatis, kan_smeg: M. kansasii vs.M. smegmatis. Similarly, the pairs with
M. thermoresistibile (thermo).
(TIF)
S5 Fig. Mycobacterium leprae specific proteins. The proteins identified as specific in M.
leprae genome (141 proteins) were searched against other mycobacterial species’ genomes.
The alignment results are plotted as sequence identity vs. query coverage. The proteins which
have a hit of at least 40% query coverage and 40% sequence identity were excluded from the
M. leprae species specific set (marked in red rectangle, represents 55 proteins out of 141). The
remaining proteins (86) were considered for further analysis.
(TIF)
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